Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Stimulus-responsive self-assembled prodrugs in cancer therapy
Xiao Dong, Rajeev Kungur Brahma, Chao Fang, et al.
Chemical Science (2022) Vol. 13, Iss. 15, pp. 4239-4269
Open Access | Times Cited: 84

Showing 1-25 of 84 citing articles:

Emerging Strategies in Stimuli-Responsive Prodrug Nanosystems for Cancer Therapy
Chendi Ding, Chunbo Chen, Xiaowei Zeng, et al.
ACS Nano (2022) Vol. 16, Iss. 9, pp. 13513-13553
Open Access | Times Cited: 98
Doxorubicin prodrug-based nanomedicines for the treatment of cancer
Haibo Zhao, Jing Yu, Renshuai Zhang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 258, pp. 115612-115612
Closed Access | Times Cited: 51
Package delivered: folate receptor-mediated transporters in cancer therapy and diagnosis
Mohsen Ahmadi, Christoph A. Ritter, Thomas von Woedtke, et al.
Chemical Science (2024) Vol. 15, Iss. 6, pp. 1966-2006
Open Access | Times Cited: 20
Self-assembled nanoformulations of paclitaxel for enhanced cancer theranostics
Qing Pei, Bowen Jiang, Dengyuan Hao, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 8, pp. 3252-3276
Open Access | Times Cited: 27
pH-responsive self-assembled nanoparticles for tumor-targeted drug delivery
Henglai Sun, Xinyu Li, Qian Liu, et al.
Journal of drug targeting (2024) Vol. 32, Iss. 6, pp. 672-706
Closed Access | Times Cited: 9
Bioorthogonal Strategy-Triggered In situ Co-Activation of Aggregation-Induced Emission Photosensitizers and Chemotherapeutic Prodrugs for Boosting Synergistic Chemo-Photodynamic-Immunotherapy
Yu Teng, Dianyu Wang, Wenlong Yang, et al.
Biomaterials (2025) Vol. 317, pp. 123092-123092
Closed Access | Times Cited: 1
Reactive oxygen species-responsive Pre-PROTAC for tumor-specific protein degradation
Haixia Liu, Chaowei Ren, Renhong Sun, et al.
Chemical Communications (2022) Vol. 58, Iss. 72, pp. 10072-10075
Closed Access | Times Cited: 37
Stimuli‐Responsive Prodrug Chemistries for Cancer Therapy
Rupa Bargakshatriya, Sumit Kumar Pramanik
ChemBioChem (2023) Vol. 24, Iss. 18
Closed Access | Times Cited: 21
Tumor Metabolism-Rewriting Nanomedicines for Cancer Immunotherapy
Xiao Dong, Xia Shu, Shubo Du, et al.
ACS Central Science (2023) Vol. 9, Iss. 10, pp. 1864-1893
Open Access | Times Cited: 20
Nanoassemblies of Self-Immolative Boronate-Bridged Retinoic Acid Dimeric Prodrug as a Clot-Targeted Self-Deliverable Antithrombotic Nanomedicine
Hayoung Jun, Chanhee Jeon, Sooyeon Kim, et al.
ACS Nano (2023) Vol. 17, Iss. 13, pp. 12336-12346
Closed Access | Times Cited: 19
Camptothecin-based prodrug nanomedicines for cancer therapy
Renshuai Zhang, Jing Yu, Zhu Guo, et al.
Nanoscale (2023) Vol. 15, Iss. 44, pp. 17658-17697
Closed Access | Times Cited: 19
Dextran-doxorubicin prodrug nanoparticles conjugated with CD147 monoclonal antibody for targeted drug delivery in hepatoma therapy
Hongrui Tian, Yu Liang, Mingzu Zhang, et al.
Colloids and Surfaces B Biointerfaces (2023) Vol. 228, pp. 113400-113400
Closed Access | Times Cited: 18
Satellite‐Type Sulfur Atom Distribution in Trithiocarbonate Bond‐Bridged Dimeric Prodrug Nanoassemblies: Achieving Both Stability and Activatability
Lingxiao Li, Tian Liu, Shiyi Zuo, et al.
Advanced Materials (2023) Vol. 36, Iss. 4
Open Access | Times Cited: 17
Activatable theranostic prodrug scaffold with tunable drug release rate for sequential photodynamic and chemotherapy
Si‐Yu Wang, Yinghao Pan, Yu‐Chen Qu, et al.
Smart Molecules (2024) Vol. 2, Iss. 1
Closed Access | Times Cited: 7
Single Molecular Nanomedicines Based on Macrocyclic Carrier-Drug Conjugates for Concentration-Independent Encapsulation and Precise Activation of Drugs
Shunyu Yao, An‐Kang Ying, Ze-Tao Jiang, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 20, pp. 14203-14212
Closed Access | Times Cited: 7
Dextran-based micelles for combinational chemo-photodynamic therapy of tumors via in vivo chemiluminescence
Chendi Ding, Zhaoqing Shi, Meitong Ou, et al.
Carbohydrate Polymers (2023) Vol. 319, pp. 121192-121192
Closed Access | Times Cited: 15
Stimulus‐Responsive Nano‐Prodrug Strategies for Cancer Therapy: A Focus on Camptothecin Delivery
Bingyang Chu, Hanzhi Deng, Ting Niu, et al.
Small Methods (2023) Vol. 8, Iss. 8
Closed Access | Times Cited: 15
Disulfide Bond-Based SN38 Prodrug Nanoassemblies with High Drug Loading and Reduction-Triggered Drug Release for Pancreatic Cancer Therapy
Zhi-Xin Zhong, Xu‐zhao Li, Jintao Liu, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 1281-1298
Open Access | Times Cited: 13
Smart Delivery Systems Responsive to Cathepsin B Activity for Cancer Treatment
Vera S. Egorova, Ekaterina Kolesova, Manu Lopus, et al.
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1848-1848
Open Access | Times Cited: 13
Recent Advances in Engineering Prodrug-based Nanomedicines for Cancer Therapy
Linlin Shi, Shanshan Lin, Fengping Zhou, et al.
Materials Advances (2024) Vol. 5, Iss. 11, pp. 4634-4659
Open Access | Times Cited: 5
ROS-triggered cycle amplification effect: A prodrug activation nanoamplifier for tumor-specific therapy
Zeqian Huang, Yaqing Ding, Yong Luo, et al.
Acta Biomaterialia (2022) Vol. 152, pp. 367-379
Closed Access | Times Cited: 19
Bioorthogonal Bond Cleavage Chemistry for On-demand Prodrug Activation: Opportunities and Challenges
Qingqiang Min, Xingyue Ji
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 24, pp. 16546-16567
Closed Access | Times Cited: 12
Targeting self-enhanced ROS-responsive artesunatum prodrug nanoassembly potentiates gemcitabine activity by down-regulating CDA expression in cervical cancer
Shengtao Wang, Kunyi Yu, Zhiyu Yu, et al.
Chinese Chemical Letters (2023) Vol. 34, Iss. 7, pp. 108184-108184
Closed Access | Times Cited: 11
Carboxylated paclitaxel prodrug nanofibers for enhanced chemotherapy
Shaojin Lu, Dengyuan Hao, Xiujuan Xiang, et al.
Journal of Controlled Release (2023) Vol. 355, pp. 528-537
Closed Access | Times Cited: 11
Dual stimulus-triggered bioorthogonal nanosystem for spatiotemporally controlled prodrug activation and near-infrared fluorescence imaging
Zhongyi Zhao, Qingyu Zong, Jun Li, et al.
Chemical Communications (2023) Vol. 59, Iss. 26, pp. 3878-3881
Closed Access | Times Cited: 11
Page 1 - Next Page

Scroll to top